glp 1 for dementia Dementia: Could GLP1 Receptor Agonists Be An Effective Treatment? Time to dementia with GLP‐1

BENEFITS Dual-pathway design GHRH-receptor and GHS-R engagement in a single formulation Convenience eliminates the need to source and reconstitute two separate vials Fixed 2:1 ratio consistent, reproducible co-administration across runs Complementary mechanisms the two classes are studied for additive rather than overlapping effects Verified identity both components MS-confirmed against a Janoshik report WHAT RESEARCHERS LOOK AT Synergistic vs additive effects of GHRH and GHS-R co-administration Comparative signalling: blend vs each compound administered alone Optimal GHRH:GHS-R ratios in combined formulations Pulsatility profiles from dual-receptor engagement Stability of a two-component lyophilized blend over storage QUICK SPECS Form: Lyophilized peptide blend Net per vial: 18 mg total (Tesamorelin 12mg + Ipamorelin 6mg) Purity: 99% (HPLC verified) Identity: MS-verified (per COA) Storage: 28C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS Components: Tesamorelin (CAS 218949-48-5) + Ipamorelin (CAS 170851-70-4) Blend ratio: 2:1 (12mg Tesamorelin : 6mg Ipamorelin) Classes: GHRH(1-44) analog + selective GHS-R (ghrelin receptor) agonist Ipamorelin sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 (pentapeptide) WHY CHOOSE DURHAM PEPTIDES FOR THE TESAMORELIN + IPAMORELIN BLEND

He recommends incorporating weight-bearing exercises into your routine and increasing your calcium, vitamin D and protein intake to lower the risk of muscle and bone loss

Answer: Mild irritation (redness, stinging, dryness) especially at the start is possible

DNA is composed of four units (called bases) that are designated A, T, G, and C

The glucosamine molecule is then absorbed in the intestine, while the remaining molecule completely disappears among the numerous hydrochloric acid molecules (-HCl) in the gastric juice

A deep dive into GLP1 agonists